GE Healthcare completes spin-off and goes public on Nasdaq

• A leader in precision medicine, committed to creating unbounded medical care

• Outstanding financial performance, thanks to the company's commitment to accelerating growth, improving margins and free cash flow through its own business growth, business optimization and careful capital allocation.

• Listed on NASDAQ under the stock code "GEHC"

GE's spin-off plan has been completed, and GE Healthcare will begin listing on the Nasdaq Stock Exchange as an independent company with the stock code "GEHC", effective today. GE Healthcare will be the first company in Wisconsin to remotely ring the NASDAQ listing bell. The company's leadership team will be present at GE Healthcare's Waukesha, Wisconsin, Wisconsin facility, where employees from around the world will also gather online and offline.

Peter Arduini, President and CEO of GE Healthcare, said: "Today is an extremely exciting day for GE Healthcare as we become an independent The company has opened a new chapter of becoming a global leader in precision medicine. We are about to usher in a real industry transformation, digital innovation reshaping the patient experience, bringing more precision, more connected and more efficient medical care Multiple needs. GE Healthcare employees around the world are working together to create borderless medical care, and we look forward to presenting such a world to our medical institutions, patients and shareholders in the future."

GE Healthcare expects the company's addressable market to grow from $84 billion in 2021 to $102 billion in 2025. This growth will bring huge business opportunities for the company's development, promote the execution of precision medicine strategies, and safely and reliably integrate patient data from medical imaging, laboratory, pathology, genomics and other channels. With Edison's digital medical intelligence platform and application software, precision medicine will stratify data through artificial intelligence. This precision medicine strategy provides insights for clinicians to diagnose diseases and determine more appropriate treatment options, so that patients can enjoy better treatment outcomes.

The spin-off of GE Healthcare was accomplished by distributing approximately 80.1% of GE Healthcare's shares held by GE in accordance with the shareholding ratio of GE's existing shareholders. GE will retain approximately 19.9% of GE Healthcare's outstanding common stock following the split.